Aclaris Therapeutics
A company developing treatments for dermatology and immunology.
All edits by Liron Shapira
Edits on 30 Apr, 2019
Liron Shapira
Edits made to:
Article (+8/-8 characters)
Article
Aclaris has two commercialized products in its portfolio, Eskata and Rhofade. Eskata is topical treatment for SKs (seborrheic keratoses). SKs are harmless spots that pop up as a person ages. Rhofade on the other hand, is a topical treatment for persistent facial erythema associated with rosacea in adults. Rhofade was originally developed by AllerganAllergan, which Aclaris then acquired the worldwide rights to.
Find more companies like Aclaris Therapeutics
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
By using this site, you agree to our Terms of Service.